Previous 10 | Next 10 |
The healthcare sector has benefited from the biotech and pharmaceutical industry's efforts to develop COVID-19 therapeutics and vaccines. Most of the big pharma companies have stepped up and led the way with antivirals, antibodies, and are committed to producing millions of doses of their vacc...
National General Holdings (NASDAQ: NGHC ) +66% on being acquired by Allstate. More news on: National General Holdings Corp., NanoViricides, Inc., Intersect ENT, Inc., Stocks on the move, , Read more ...
Insider buying decreased last week with insiders purchasing $183.24 million of stock compared to $286.95 million in the week prior. Selling also decreased with insiders selling $975.88 million of stock last week compared to $2.21 billion in the week prior. Given that we are at the start of a n...
NantKwest (NK) has been one of my best investments over the past year and looks to be ready to move higher following another positive data for cancer and development of a COVID-19 vaccine. Recently, the company's CEO, Dr. Patrick Soon-Shiong "PSS", has been on some news segments discussing som...
NantKwest, Inc. (Nasdaq: NK), a clinical-stage, natural killer cell-based therapeutics company, announced today the closing of its previously announced underwritten public offering of an aggregate of 8,521,500 shares of its common stock (4,811,500 shares at a price to the public of $9.50 per ...
UniQure N.V. (NASDAQ: QURE ) -16% after hemophilia gene therapy deal . More news on: uniQure N.V., KB Home, Kaleyra, Inc., Stocks on the move, , Read more ...
NantKwest (NASDAQ: NK ) has priced its public offering of 7.41M common stock (3.7M shares at a public offering price of $9.50/share and 3.71M shares at $12.12/share to Dr. Patrick Soon-Shiong, CEO and and principal stockholder). More news on: NantKwest, Inc., Healthcare st...
NantKwest, Inc. (Nasdaq: NK), a clinical-stage, natural killer cell-based therapeutics company, today announced the pricing of an underwritten public offering of an aggregate of 7,410,000 shares of its common stock (3,700,000 shares at a price to the public of $9.50 per share and 3,710,000 sh...
Gainers: ALLY +14.7% . BBD +7.9% . CLPS +7.1% . NVST +5.1% . HLX +4.1% . More news on: Ally Financial Inc., Banco Bradesco S.A., CLPS Incorporation, Stocks on the move, , Read more ...
NantKwest (NASDAQ: NK ) to offer shares in an underwritten public offering, and underwriters will have an option to purchase up to an additional 15% of the shares offered. More news on: NantKwest, Inc., Healthcare stocks news, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
NantKwest Company Name:
NK Stock Symbol:
NASDAQ Market:
Imerys Enters Long-Term Partnership with TotalEnergies for Renewable Power at its Santa Barbara County Facility PR Newswire A TotalEnergies solar and battery storage solution to bring 130-year-old Lompoc industrial site into new era of sustainability and smart energy manag...
Creates Leading Immunotherapy and Cell Therapy Company ImmunityBio , Inc. and NantKwest , Inc. ( NASDAQ: NK ), today announced the completion of their previously announced 100% stock-for-stock merger. This follows the satisfaction of all customary closing conditi...
NantKwest, Inc . ( NASDAQ: NK ), a clinical-stage, natural killer cell-based therapeutics company, today announced that its stockholders approved by the required vote each of the proposals related to the pending merger of NantKwest and ImmunityBio, Inc. presented at the special ...